The Eph tyrosine kinase receptors EphB2 and EphA2 are novel proteolytic substrates of tissue factor/coagulation factor VIIa

Journal of Biological Chemistry

Volumn 289, Issue 47, 2014, Pages 32379-32391

  Eriksson, Oskar ^a,c   Ramström, Margareta ^b,c   Hörnaeus, Katarina ^b,c   Bergquist, Jonas ^b,c   Mokhtari, Dariush ^a,c   Siegbahn, Agneta ^a,c  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

^c UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACIDS; CELLS; COAGULATION; CYTOLOGY; ENZYMES; SURFACE PLASMON RESONANCE; TISSUE;

ACTIVE COMPLEXES; ANTIBODY ARRAYS; ARGININE RESIDUE; CELL SEGREGATIONS; CELLULAR FUNCTION; N-TERMINAL EDMAN SEQUENCING; PROTEASE-ACTIVATED RECEPTOR 2; TYROSINE-KINASE RECEPTORS;

CELL SIGNALING;

ARGININE; BLOOD CLOTTING FACTOR 7A; EPHRIN B1; EPHRIN RECEPTOR A2; EPHRIN RECEPTOR B2; PROTEINASE ACTIVATED RECEPTOR 2; THROMBOPLASTIN; BLOOD CLOTTING FACTOR 7; DISULFIDE; PROTEIN BINDING;

AMINO TERMINAL SEQUENCE; ARTICLE; BLOOD CLOTTING; CELL MIGRATION ASSAY; CONTROLLED STUDY; DISULFIDE BOND; ENZYME ACTIVITY; ENZYME SUBSTRATE; HUMAN; HUMAN CELL; INTRACELLULAR SIGNALING; LIGAND BINDING; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; OXIDATION REDUCTION STATE; PROTEIN CLEAVAGE; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; SEQUENCE ANALYSIS; AMINO ACID SEQUENCE; BINDING SITE; CELL CULTURE; CELL MOTION; CHEMICAL STRUCTURE; CHEMISTRY; ENZYME SPECIFICITY; GENETICS; METABOLISM; MOLECULAR GENETICS; OXIDATION REDUCTION REACTION; PROTEIN TERTIARY STRUCTURE; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION; TANDEM MASS SPECTROMETRY; TUMOR CELL LINE; WESTERN BLOTTING;

AMINO ACID SEQUENCE; BINDING SITES; BLOTTING, WESTERN; CELL LINE, TUMOR; CELL MOVEMENT; CELLS, CULTURED; DISULFIDES; FACTOR VII; FACTOR VIIA; HUMANS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; OXIDATION-REDUCTION; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; PROTEOLYSIS; RECEPTOR, EPHA2; RECEPTOR, EPHB2; SEQUENCE ANALYSIS, PROTEIN; SEQUENCE HOMOLOGY, AMINO ACID; SIGNAL TRANSDUCTION; SUBSTRATE SPECIFICITY; TANDEM MASS SPECTROMETRY; THROMBOPLASTIN;

EID: 84911440899     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M114.599332     Document Type: Article

References (46)

1. Janes, P. W., Nievergall, E., and Lackmann, M. (2012) Concepts and consequences of Eph receptor clustering. Semin. Cell Dev. Biol. 23, 43-50
2. Lackmann, M., and Boyd, A. W. (2008) Eph, a protein family coming of age: more confusion, insight, or complexity? Sci. Signal. 1, re2
3. Pasquale, E. B. (2010) Eph receptors and ephrins in cancer: bidirectional signalling and beyond. Nat. Rev. Cancer 10, 165-180
4. Pitulescu, M. E., and Adams, R. H. (2010) Eph/Ephrin molecules: a hub for signaling and endocytosis. Genes Dev. 24, 2480-2492
5. Batlle, E., Henderson, J. T., Beghtel, H., van den Born, M. M., Sancho, E., Huls, G., Meeldijk, J., Robertson, J., van de Wetering, M., Pawson, T., and Clevers, H. (2002) β-Catenin and TCF mediate cell positioning in the intestinal epithelium by controlling the expression of EphB/EphrinB. Cell 111, 251-263
6. Lin, K.-T., Sloniowski, S., Ethell, D. W., and Ethell, I. M. (2008) Ephrin-B2-induced cleavage of EphB2 receptor is mediated by matrix metalloproteinases to trigger cell repulsion. J. Biol. Chem. 283, 28969-28979
7. Sugiyama, N., Gucciardo, E., Tatti, O., Varjosalo, M., Hyytiäinen, M., Gstaiger, M., and Lehti, K. (2013) EphA2 cleavage by MT1-MMP triggers single cancer cell invasion via homotypic cell repulsion. J. Cell Biol. 201, 467-484
8. Janes, P. W., Saha, N., Barton, W. A., Kolev, M. V., Wimmer-Kleikamp, S. H., Nievergall, E., Blobel, C. P., Himanen, J.-P., Lackmann, M., and Nikolov, D. B. (2005) Adam meets Eph: an ADAM substrate recognition module acts as a molecular switch for ephrin cleavage in Trans. Cell 123, 291-304
9. Drake, T. A., Morrissey, J. H., and Edgington, T. S. (1989) Selective cellular expression of tissue factor in human tissues: implications for disorders of hemostasis and thrombosis. Am. J. Pathol. 134, 1087-1097
10. Callander, N. S., Varki, N., and Rao, L. V. (1992) Immunohistochemical identification of tissue factor in solid tumors. Cancer 70, 1194-1201
11. Toschi, V., Gallo, R., Lettino, M., Fallon, J. T., Gertz, S. D., Fernández-Ortiz, A., Chesebro, J. H., Badimon, L., Nemerson, Y., Fuster, V., and Badimon, J. J. (1997) Tissue factor modulates the thrombogenicity of human atherosclerotic plaques. Circulation 95, 594-599
12. Versteeg, H. H., Schaffner, F., Kerver, M., Petersen, H. H., Ahamed, J., Felding-Habermann, B., Takada, Y., Mueller, B. M., and Ruf, W. (2008) Inhibition of tissue factor signaling suppresses tumor growth. Blood 111, 190-199
13. Ruf, W., Disse, J., Carneiro-Lobo, T. C., Yokota, N., and Schaffner, F. (2011) Tissue factor and cell signalling in cancer progression and thrombosis. J. Thromb. Haemost. 9, 306-315
14. Siegbahn, A., Johnell, M., Nordin, A., Aberg, M., and Velling, T. (2008) TF/FVIIa transactivate PDGFRβ to regulate PDGF-BB-induced chemotaxis in different cell types involvement of Src and PLC. Arterioscler. Thromb. Vasc. Biol. 28, 135-141
15. Belting, M., Dorrell, M. I., Sandgren, S., Aguilar, E., Ahamed, J., Dorfleutner, A., Carmeliet, P., Mueller, B. M., Friedlander, M., and Ruf, W. (2004) Regulation of angiogenesis by tissue factor cytoplasmic domain signaling. Nat. Med. 10, 502-509
16. Badeanlou, L., Furlan-Freguia, C., Yang, G., Ruf, W., and Samad, F. (2011) Tissue factor-protease-activated receptor 2 signaling promotes diet-induced obesity and adipose inflammation. Nat. Med. 17, 1490-1497
17. Aberg, M., Johnell, M., Wickström, M., and Siegbahn, A. (2011) Tissue factor/FVIIa prevents the extrinsic pathway of apoptosis by regulation of the tumor suppressor death-associated protein kinase 1 (DAPK1). Thromb. Res. 127, 141-148
18. A˚berg, M., Eriksson, O., Mokhtari, D., and Siegbahn, A. (2014) Tissue factor/factor VIIa induces cell survival and gene transcription by transactivation of the insulin-like growth factor 1 receptor. Thromb. Haemost. 111, 748-760
19. Ramström, M., Zuberovic, A., Grönwall, C., Hanrieder, J., Bergquist, J., and Hober, S. (2009) Development of affinity columns for the removal of high-abundance proteins in cerebrospinal fluid. Biotechnol. Appl. Biochem. 52, 159-166
20. Morrissey, J. H., Fair, D. S., and Edgington, T. S. (1988) Monoclonal antibody analysis of purified and cell-associated tissue factor. Thromb. Res. 52, 247-261
21. Ruf, W., and Edgington, T. S. (1991) An anti-tissue factor monoclonal antibody which inhibits TF·VIIa complex is a potent anticoagulant in plasma. Thromb. Haemost. 66, 529-533
22. Ahamed, J., Versteeg, H. H., Kerver, M., Chen, V. M., Mueller, B. M., Hogg, P. J., and Ruf, W. (2006) Disulfide isomerization switches tissue factor from coagulation to cell signaling. Proc. Natl. Acad. Sci. U.S.A. 103, 13932-13937
23. Neuenschwander, P. F., and Morrissey, J. H. (1995) Alteration of the substrate and inhibitor specificities of blood coagulation factor VIIa: importance of amino acid residue K192. Biochemistry 34, 8701-8707
24. Söderberg, O., Leuchowius, K.-J., Gullberg, M., Jarvius, M., Weibrecht, I., Larsson, L.-G., and Landegren, U. (2008) Characterizing proteins and their interactions in cells and tissues using the in situ proximity ligation assay. Methods 45, 227-232
25. Shirk, R. A., and Vlasuk, G. P. (2007) Inhibitors of Factor VIIa/tissue factor. Arterioscler. Thromb. Vasc. Biol. 27, 1895-1900
26. Wang, S. D., Rath, P., Lal, B., Richard, J.-P., Li, Y., Goodwin, C. R., Laterra, J., and Xia, S. (2012) EphB2 receptor controls proliferation/migration dichotomy of glioblastoma by interacting with focal adhesion kinase. Oncogene 31, 5132-5143
27. Fox, B. P., and Kandpal, R. P. (2004) Invasiveness of breast carcinoma cells and transcript profile: Eph receptors and ephrin ligands as molecular markers of potential diagnostic and prognostic application. Biochem. Biophys. Res. Commun. 318, 882-892
28. MacBeath, G. (2002) Protein microarrays and proteomics. Nat. Genet. 32, 526-532
29. Lee, C., Dixelius, J., Thulin, A., Kawamura, H., Claesson-Welsh, L., and Olsson, A.-K. (2006) Signal transduction in endothelial cells by the angiogenesis inhibitor histidine-rich glycoprotein targets focal adhesions. Exp. Cell Res. 312, 2547-2556
30. Zhang, Q., Petersen, H. H., Ostergaard, H., Ruf, W., and Olson, A. J. (2009) Molecular dynamics simulations and functional characterization of the interactions of the PAR2 ectodomain with factor VIIa. Proteins 77, 559-569
31. Bergum, P. W., Cruikshank, A., Maki, S. L., Kelly, C. R., Ruf, W., and Vlasuk, G. P. (2001) Role of zymogen and activated Factor X as scaffolds for the inhibition of the blood coagulation Factor VIIa-tissue factor complex by recombinant nematode anticoagulant protein c2. J. Biol. Chem. 276, 10063-10071
32. Gailani, D., and Smith, S. B. (2009) Structural and functional features of factor XI. J. Thromb. Haemost. 7, 75-78
33. Himanen, J. P., Goldgur, Y., Miao, H., Myshkin, E., Guo, H., Buck, M., Nguyen, M., Rajashankar, K. R., Wang, B., and Nikolov, D. B. (2009) Ligand recognition by A-class Eph receptors: crystal structures of the EphA2 ligand-binding domain and the EphA2/ephrin-A1 complex. EMBO Rep. 10, 722-728
34. Kazanov, M. D., Igarashi, Y., Eroshkin, A. M., Cieplak, P., Ratnikov, B., Zhang, Y., Li, Z., Godzik, A., Osterman, A. L., and Smith, J. W. (2011) Structural determinants of limited proteolysis. J. Proteome Res. 10, 3642-3651
35. Solanas, G., Cortina, C., Sevillano, M., and Batlle, E. (2011) Cleavage of E-cadherin by ADAM10 mediates epithelial cell sorting downstream of EphB signalling. Nat. Cell Biol. 13, 1100-1107
36. Kryczka, J., Stasiak, M., Dziki, L., Mik, M., Dziki, A., and Cierniewski, C. (2012) Matrix metalloproteinase-2 cleavage of the β1 integrin ectodomain facilitates colon cancer cell motility. J. Biol. Chem. 287, 36556-36566
37. Stathakis, P., Lay, A. J., Fitzgerald, M., Schlieker, C., Matthias, L. J., and Hogg, P. J. (1999) Angiostatin formation involves disulfide bond reduction and proteolysis in Kringle 5 of plasmin. J. Biol. Chem. 274, 8910-8916
38. Cook, K. M., and Hogg, P. J. (2013) Post-translational control of protein function by disulfide bond cleavage. Antioxid. Redox Signal. 18, 1987-2015
39. Metcalfe, C., Cresswell, P., Ciaccia, L., Thomas, B., and Barclay, A. N. (2011) Labile disulfide bonds are common at the leucocyte cell surface. Open Biol. 1, 110010
40. Kask, L., Jorsback, A., Winkvist, M., Alfredsson, J., Ek, B., Bergquist, J., and Siegbahn, A. (2014) Identification of novel downstream molecules of tissue factor activation by comparative proteomic analysis. J. Proteome Res. 13, 477-488
41. Sakamoto, A., Ishibashi-Ueda, H., Sugamoto, Y., Higashikata, T., Miyamoto, S., Kawashiri, M. A., Yagi, K., Konno, T., Hayashi, K., Fujino, N., Ino, H., Takeda, Y., and Yamagishi, M. (2008) Expression and function of ephrin-B1 and its cognate receptor EphB2 in human atherosclerosis: from an aspect of chemotaxis. Clin. Sci. 114, 643-650
42. Liu, H., Devraj, K., Möller, K., Liebner, S., Hecker, M., and Korff, T. (2014) EphrinB-mediated reverse signalling controls junctional integrity and pro-inflammatory differentiation of endothelial cells: Thromb. Haemost. 112, 151-163
43. Morrissey, J. H., Macik, B. G., Neuenschwander, P. F., and Comp, P. C. (1993) Quantitation of activated factor VII levels in plasma using a tissue factor mutant selectively deficient in promoting factor VII activation. Blood 81, 734-744
44. Goldgur, Y., Paavilainen, S., Nikolov, D., and Himanen, J. P. (2009) Structure of the ligand-binding domain of the EphB2 receptor at 2-A˚ resolution. Acta Crystallogr. Sect. F Struct. Biol. Cryst. Commun. 65, 71-74
45. Guex, N., and Peitsch, M. C. (1997) SWISS-MODEL and the Swiss-Pdb-Viewer: an environment for comparative protein modeling. Electrophoresis 18, 2714-2723
46. Miao, H., Li, D.-Q., Mukherjee, A., Guo, H., Petty, A., Cutter, J., Basilion, J. P., Sedor, J., Wu, J., Danielpour, D., Sloan, A. E., Cohen, M. L., and Wang, B. (2009) EphA2 mediates ligand-dependent inhibition and ligand-independent promotion of cell migration and invasion via a reciprocal regulatory loop with Akt. Cancer Cell 16, 9-20